Both in Pharmaceuticals
CAMP4 Therapeutics vs Immuneering
Over the past year CAMP returned −0.8% and IMRX returned −44.1%; their daily moves had a correlation of 0.11.
CAMP −0.8% IMRX −44.1%Growth of $1, one year, split-adjusted
| Metric | CAMP | IMRX |
|---|---|---|
| Price | $3.91 | $3.67 |
| Market cap | $245.4M | $237.7M |
| Today | +3.58% | +5.16% |
| 1 month | −2.5% | −9.2% |
| 6 months | −1.8% | −31.3% |
| Year to date | −36.2% | −44.2% |
| 1 year | −6.0% | −46.6% |
| Revenue growth (YoY) | +18.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −1884.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 58.2× | — |
| Net cash | $86.4M | $145.4M |
| Dividend yield | — | — |
| Volatility (60d) | 84.1% | 53.7% |
| Short % of float | 8.2% | 29.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).